Literature DB >> 26723084

Proton radiotherapy for primary liver cancers.

Michael Granovetter.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26723084     DOI: 10.1016/S1470-2045(15)00616-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

Review 1.  Charged-particle therapy in cancer: clinical uses and future perspectives.

Authors:  Marco Durante; Roberto Orecchia; Jay S Loeffler
Journal:  Nat Rev Clin Oncol       Date:  2017-03-14       Impact factor: 66.675

2.  Assessing the uncertainty in a normal tissue complication probability difference (∆NTCP): radiation-induced liver disease (RILD) in liver tumour patients treated with proton vs X-ray therapy.

Authors:  Keiji Kobashi; Anussara Prayongrat; Takuya Kimoto; Chie Toramatsu; Yasuhiro Dekura; Norio Katoh; Shinichi Shimizu; Yoichi M Ito; Hiroki Shirato
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724

3.  Indicator for local recurrence of hepatocellular carcinoma after proton beam therapy: analysis of attenuation difference between the irradiated tumor and liver parenchyma on contrast enhancement CT.

Authors:  Hiroaki Takahashi; Yuta Sekino; Kensaku Mori; Toshiyuki Okumura; Katsuhiro Nasu; Kuniaki Fukuda; Sota Masuoka; Takashi Iizumi; Naoyuki Hasegawa; Hideyuki Sakurai; Manabu Minami
Journal:  Br J Radiol       Date:  2019-11-07       Impact factor: 3.039

4.  Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma.

Authors:  Luca Cozzi; Tiziana Comito; Antonella Fogliata; Ciro Franzese; Stefano Tomatis; Marta Scorsetti
Journal:  PLoS One       Date:  2018-08-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.